Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - hydrocortisone 5mg;   - tablet - 5 mg - active: hydrocortisone 5mg   excipient: lactose monohydrate magnesium stearate maize starch povidone purified talc

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cilastatin sodium 530.7mg equivalent to 500 mg cilastatin; imipenem monohydrate 530.1mg equivalent to 500 mg imipenem - powder for injection - 500mg/500mg - active: cilastatin sodium 530.7mg equivalent to 500 mg cilastatin imipenem monohydrate 530.1mg equivalent to 500 mg imipenem excipient: sodium bicarbonate - indicated for the treatment of the following infections due to susceptible organisms: · intra-abdominal infections · lower respiratory tract infections · gynaecological infections · septicaemia · genitourinary tract infections · bone and joint infections · skin and soft tissue infections · endocarditis indicated for the treatment of mixed infections caused by susceptible strains of aerobic and anaerobic bacteria. the majority of these mixed infections are associated with contamination by faecal flora or flora originating from the vagina, skin and mouth. in these mixed infections, bacteroides fragilis is the most commonly encountered anaerobic pathogen and is usually resistant to aminoglycosides, ephalosporins and penicillins. however, bacteroides fragilis is usually susceptible to imipenem and cilastatin combination. imipenem and cilastatin combination has demonstrated efficacy against many infections caused by aerobic and anaerobic gram-positive and gram-negative bacteria resistant to the cephalosporins, including cefazolin, cefoperazone, cephalothin, cefoxitin, cefotaxime, moxalactam, cefamandole, ceftazidime and ceftriaxone. similarly, many infections caused by organisms resistant to aminoglycosides (gentamicin, amikacin, tobramycin) and/or penicillins (ampicillin, carbenicillin, penicillin-g, ticarcillin, piperacillin, azlocillin, mezlocillin) responded to treatment imipenem and cilastatin. imipenem+cilastatin rbx is not indicated for the treatment of meningitis.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - aciclovir 200mg;   - dispersible tablet - 200 mg - active: aciclovir 200mg   excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water sodium starch glycolate - · treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. · suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. · prophylaxis of herpes simplex infections in immune-competent patients. · treatment of acute herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster associated pain and for the reduction of the incidence and duration of postherpetic neuralgia. · management of patients with severe aids who have a cd4 count of less than 50/µl. studies have shown that oral aciclovir given in conjunction with antiretroviral therapy reduced mortality in patients with advanced hiv disease. · patients undergoing allogenic bone marrow transplantation who are at risk of developing cmv infection while immunosuppressed (preceded by one month's treatment with intravenous aciclovir). studies have shown that oral aciclovir reduced mortality in allogenic bone marrow transplant recipients. in addition oral aciclovir provided effective prophylaxis for herpes virus disease.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - aciclovir 800mg;   - dispersible tablet - 800 mg - active: aciclovir 800mg   excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water sodium starch glycolate - · treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. · suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. · prophylaxis of herpes simplex infections in immune-competent patients. · treatment of acute herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster associated pain and for the reduction of the incidence and duration of postherpetic neuralgia. · management of patients with severe aids who have a cd4 count of less than 50/µl. studies have shown that oral aciclovir given in conjunction with antiretroviral therapy reduced mortality in patients with advanced hiv disease. · patients undergoing allogenic bone marrow transplantation who are at risk of developing cmv infection while immunosuppressed (preceded by one month's treatment with intravenous aciclovir). studies have shown that oral aciclovir reduced mortality in allogenic bone marrow transplant recipients. in addition oral aciclovir provided effective prophylaxis for herpes virus disease.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - indapamide hemihydrate 2.5mg - tablet - 2.5 mg - active: indapamide hemihydrate 2.5mg excipient: hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink oy-6925 sodium laurilsulfate

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - nifedipine 20mg;   - modified release tablet - 20 mg - active: nifedipine 20mg   excipient: iron oxide black iron oxide red lactose monohydrate macrogol 4000 magnesium stearate methylcellulose microcrystalline cellulose polysorbate 80 pregelatinised maize starch purified water titanium dioxide

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - isotretinoin 10mg;  ;   - soft gelatin capsule - 10 mg - active: isotretinoin 10mg     excipient: butylated hydroxyanisole disodium edetate dihydrate dl-alpha tocopherol gelatin glycerol hydrogenated vegetable oil iron oxide black ponceau 4r purified water sorbitol soya oil titanium dioxide yellow beeswax - severe forms of nodulo-cystic acne which are resistant to therapy, particularly cystic acne and acne conglobata, especially when the lesions involve the trunk. oratane should only be prescribed by physicians who are experienced in the use of systemic retinoids, preferably dermatologists, and understand the risk of teratogenicity if oratane is used during pregnancy.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - isotretinoin 20mg;  ;   - soft gelatin capsule - 20 mg - active: isotretinoin 20mg     excipient: butylated hydroxyanisole disodium edetate dihydrate dl-alpha tocopherol gelatin glycerol hydrogenated vegetable oil indigo carmine ponceau 4r purified water sorbitol soya oil titanium dioxide yellow beeswax - severe forms of nodulo-cystic acne which are resistant to therapy, particularly cystic acne and acne conglobata, especially when the lesions involve the trunk. oratane should only be prescribed by physicians who are experienced in the use of systemic retinoids, preferably dermatologists, and understand the risk of teratogenicity if oratane is used during pregnancy.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - isotretinoin 30mg;  ;   - soft gelatin capsule - 30 mg - active: isotretinoin 30mg     excipient: butylated hydroxyanisole disodium edetate dihydrate dl-alpha tocopherol gelatin glycerol iron oxide red sorbitol soya bean oil, hydrogenated   soya oil titanium dioxide yellow beeswax - severe forms of nodulo-cystic acne which are resistant to therapy, particularly cystic acne and acne conglobata, especially when the lesions involve the trunk.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - isotretinoin 40mg;  ;   - soft gelatin capsule - 40 mg - active: isotretinoin 40mg     excipient: butylated hydroxyanisole disodium edetate dihydrate gelatin glycerol all-rac-alpha-tocopherol purified water sorbitol soya bean oil, hydrogenated   soya oil sunset yellow fcf titanium dioxide yellow beeswax - severe forms of nodulo-cystic acne which are resistant to therapy, particularly cystic acne and acne conglobata, especially when the lesions involve the trunk. oratane should only be prescribed by physicians who are experienced in the use of systemic retinoids, preferably dermatologists, and understand the risk of teratogenicity if oratane is used during pregnancy.